Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
No data available
No data available
No data available
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 53.87 | 39.62 | 44.98 | - | - |
Total Expenses | 49.82 | 37.07 | 41.19 | - | - |
Profit Before Tax | 4.05 | 2.55 | 3.80 | - | - |
Profit After Tax | 3.03 | 1.84 | 3.35 | - | - |
Operating Profit after Depreciation | 6.16 | 3.10 | 4.31 | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 43.48 | 42.50 | 17.23 | - | - |
Total Non Current Assets | 44.58 | 44.16 | 22.41 | - | - |
Total Current Assets | 29.56 | 14.56 | 14.43 | - | - |
TOTAL ASSETS | 74.14 | 58.72 | 36.84 | - | - |
Total Shareholder's Fund | 24.88 | 18.20 | 16.38 | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 1.52 | 1.96 | 0.49 | - | - |
Net Cash used in Investing Activities | -3.15 | -22.68 | -5.78 | - | - |
Net Cash used in Financing Activities | 3.09 | 16.43 | 5.20 | - | - |
No data available
No data available
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Onyx Biotec Ltd | ₹66.35 | ₹120.31 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
22 Nov 2024, 05:38 pm